Peter Kies - 26 Feb 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
CFO
Signature
/s/ Peter Kies
Issuer symbol
INO
Transactions as of
26 Feb 2025
Net transactions value
-$10,538
Form type
4
Filing time
28 Feb 2025, 18:05:29 UTC
Previous filing
16 May 2024
Next filing
16 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +3,997 +16% 28,364 26 Feb 2025 Direct F1
transaction INO Common Stock Tax liability $4,677 -2,362 -8.3% $1.98 26,002 26 Feb 2025 Direct F2
transaction INO Common Stock Options Exercise +5,010 +19% 31,012 26 Feb 2025 Direct F3
transaction INO Common Stock Tax liability $5,861 -2,960 -9.5% $1.98 28,052 26 Feb 2025 Direct F4
holding INO Common Stock 375 26 Feb 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -3,997 -100% $0.000000 0 26 Feb 2025 Common Stock 3,997 Direct F1
transaction INO Restricted Stock Unit Options Exercise $0 -5,010 -33% $0.000000 10,019 26 Feb 2025 Common Stock 5,010 Direct F3
transaction INO Common Stock Option Award $0 +39,050 $0.000000 39,050 27 Feb 2025 Common Stock 39,050 $1.94 Direct F5
transaction INO Restricted Stock Unit Award $0 +31,900 $0.000000 31,900 27 Feb 2025 Common Stock 31,900 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,991 restricted stock units granted on February 26, 2022 was as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein.
F5 The vesting schedule for the 39,050 options is as follows: 19,525 shares vested on February 27, 2025 and 19,525 shares will vest on February 26, 2026.
F6 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 is as follows: 10,634 shares will vest on February 26, 2026; 10,633 shares will vest on February 26, 2027; and 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.